CLDN1 and atopic eczema: In the case of glucose, topical glucose was shown to induce claudin-1 and filaggrin expression in a mouse model of atopic dermatitis and in keratinocyte culture, indicating that it has an anti-inflammatory effect by repairing skin barrier function [18].